3653 results for «358»
3653 results
Where are we going? The symptomatic patient with moderate aortic stenosis
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentations on symptomatic patient with moderate aortic stenosis to learn to evaluate outcomes after TAVI, to better assess aortic stenosis and LV function, and to expand your knowledge in infiltrative diseases.
Diagnosis of disease type and of disease severity
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn how to better assess mitral regurgitation and how to better diagnose mitral stenosis through imaging.
Diagnosis and classification of tricuspid regurgitation
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the anatomy of the tricuspid valve and its challenges, to know when and how to treat tricuspid regurgitation, and to discover all about the latest classification regarding this condition.
Transcatheter tricuspid valve interventions: procedural considerations
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session on transcatheter tricuspid valve interventions to know more about what to do before planning tricuspid regurgitation interventions, to understand when to perform a right heart catheterisation and to learn how to solve complications during interventions.
Transcatheter tricuspid valve interventions: outcomes
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentations to learn how to better assess transcatheter tricuspid valve interventions results, to understand what are the endpoints after interventions as well as to learn what we can expect in future guidelines.
Mixed VHD: how to manage?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn more about aortic stenosis and aortic regurgitation: how to diagnose these conditions, how to select patients for surgical or transcatheter interventions, and how to treat them.
Endocarditis: what can we suggest for the upcoming ESC guidelines?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the various challenges in treating patients with endocarditis, to understand how to better diagnose valve endocarditis and to discover new transcatheter interventions after endocarditis.
The challenge of aortic regurgitation: better imaging for better clinical practice
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn about the challenges of diagnosing aortic regurgitation and how to overcome them, to better understand the right timing for intervention based on available evidence, and to discover what tools exist to more accurately assess the severity of aortic regurgitation.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
